BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28893642)

  • 1. Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo.
    Jiang B; Meng L; Zhang F; Jin X; Zhang G
    Life Sci; 2017 Nov; 189():1-7. PubMed ID: 28893642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells.
    Cui HM; Zhang QY; Wang JL; Chen JL; Zhang YL; Tong XL
    J Ethnopharmacol; 2014 Dec; 158 Pt A():388-96. PubMed ID: 25456436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ziziphus jujuba fruit extracts on cytochrome P450 (CYP1A2) activity in rats.
    Jing XY; Peng YR; Wang XM; Duan JA
    Chin J Nat Med; 2015 Aug; 13(8):588-94. PubMed ID: 26253491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats.
    Sun J; Tang X; Xu Q; Ge T; Peng D; Chen W
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):655-664. PubMed ID: 29721716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats.
    Zhao X; Zhang JJ; Wang X; Bu XY; Lou YQ; Zhang GL
    Biomed Pharmacother; 2008 Nov; 62(9):567-72. PubMed ID: 17418998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
    Vaghela M; Sahu N; Kharkar P; Pandita N
    Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo evaluations of cytochrome P450 1A2 interactions with nuciferine.
    Hu L; Xu W; Zhang X; Su J; Liu X; Li H; Zhang W
    J Pharm Pharmacol; 2010 May; 62(5):658-62. PubMed ID: 20609070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats.
    Zhu Q; Liao J; Xie L; Wang GJ; Liu XD
    Xenobiotica; 2009 Apr; 39(4):293-301. PubMed ID: 19350452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scutellarin inhibits cytochrome P450 isoenzyme 1A2 (CYP1A2) in rats.
    Jian TY; He JC; He GH; Feng EF; Li HL; Bai M; Xu GL
    Phytother Res; 2012 Aug; 26(8):1226-30. PubMed ID: 22228482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat hepatic CYP1A1 and CYP1A2 induction by menadione.
    Sidorova YA; Grishanova AY; Lyakhovich VV
    Toxicol Lett; 2005 Feb; 155(2):253-8. PubMed ID: 15603920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.
    Lobo ED; Bergstrom RF; Reddy S; Quinlan T; Chappell J; Hong Q; Ring B; Knadler MP
    Clin Pharmacokinet; 2008; 47(3):191-202. PubMed ID: 18307373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenacetin pharmacokinetics in CYP1A2-deficient beagle dogs.
    Whiterock VJ; Morgan DG; Lentz KA; Orcutt TL; Sinz MW
    Drug Metab Dispos; 2012 Feb; 40(2):228-31. PubMed ID: 22074769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats.
    Gao N; Qi B; Liu FJ; Fang Y; Zhou J; Jia LJ; Qiao HL
    PLoS One; 2014; 9(2):e89752. PubMed ID: 24587011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of buagafuran on liver microsomal cytochrome P450 in rats.
    Li E; Hu JP; Wang BL; Li Y
    J Asian Nat Prod Res; 2010 May; 12(5):371-81. PubMed ID: 20496194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers.
    Xiaodong S; Gatti G; Bartoli A; Cipolla G; Crema F; Perucca E
    Ther Drug Monit; 1994 Jun; 16(3):248-50. PubMed ID: 8085279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.
    Qin G; Meng Z
    Toxicol Lett; 2005 Dec; 160(1):34-42. PubMed ID: 16023800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of liver cytochrome P450 1A2 expression by flutamide in rats.
    Wang HX; Liu X; Xu CJ; Ma XC; Long JE; Li D
    Acta Pharmacol Sin; 2005 Nov; 26(11):1382-6. PubMed ID: 16225762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.
    Lin K; Zhang Q; Liu Z; Yang S; Lin Y; Wen C; Zheng Y
    Int J Clin Exp Pathol; 2015; 8(5):5584-90. PubMed ID: 26191268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaminophen produces cataract in DBA2 mice by Ah receptor-independent induction of CYP1A2.
    Qian W; Shichi H
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):337-44. PubMed ID: 10977129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.